These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 26860093)

  • 61. Use of blue-on-yellow perimetry to demonstrate quadrantanopia in multiple sclerosis.
    Fujimoto N; Adachi-Usami E
    Arch Ophthalmol; 1998 Jun; 116(6):828-9. PubMed ID: 9639464
    [No Abstract]   [Full Text] [Related]  

  • 62. Visual field abnormalities in multiple sclerosis.
    Patterson VH; Heron JR
    J Neurol Neurosurg Psychiatry; 1980 Mar; 43(3):205-9. PubMed ID: 7373317
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The paracentral visual field in multiple sclerosis: evidence for a deficit in interneuronal spatial summation?
    Antal A; Aita JF; Bodis-Wollner I
    Vision Res; 2001 Jun; 41(13):1735-42. PubMed ID: 11348654
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Retinal imaging with optical coherence tomography: a biomarker in multiple sclerosis?
    Costello F; Burton JM
    Eye Brain; 2018; 10():47-63. PubMed ID: 30104912
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Magnetic resonance imaging measures of brain atrophy in multiple sclerosis.
    Anderson VM; Fox NC; Miller DH
    J Magn Reson Imaging; 2006 May; 23(5):605-18. PubMed ID: 16596564
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Acute zonal occult outer retinopathy and multiple sclerosis.
    Hintzen RQ; van den Born LI
    J Neurol Neurosurg Psychiatry; 2006 Dec; 77(12):1373-5. PubMed ID: 16868065
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Brain volume and diffusion markers as predictors of disability and short-term disease evolution in multiple sclerosis.
    Sämann PG; Knop M; Golgor E; Messler S; Czisch M; Weber F
    AJNR Am J Neuroradiol; 2012 Aug; 33(7):1356-62. PubMed ID: 22383242
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Structural sex differences at disease onset in multiple sclerosis patients.
    Rojas JI; Sánchez F; Patrucco L; Miguez J; Funes J; Cristiano E
    Neuroradiol J; 2016 Oct; 29(5):368-71. PubMed ID: 27562581
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Multiple sclerosis.
    Frohman EM
    Med Clin North Am; 2003 Jul; 87(4):867-97, viii-ix. PubMed ID: 12834152
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Rapid, non-contact multifocal visual assessment in multiple sclerosis.
    Maddess T; van Kleef JP; Rohan EMF; Carle CF; Baird-Gunning J; Rai BB; Bruestle A; Lane J; Lueck CJ
    Neurol Sci; 2023 Jan; 44(1):273-279. PubMed ID: 36098887
    [TBL] [Abstract][Full Text] [Related]  

  • 71. No evidence of disease activity in multiple sclerosis patients.
    Matta AP; Nascimento OJ; Ferreira AC; Magalhães TN; Benevides TP; Kirmse A; Dib JG; Cal H; Orsini M; Araujo LM
    Expert Rev Neurother; 2016 Nov; 16(11):1279-1284. PubMed ID: 27352830
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Optimizing treatment success in multiple sclerosis.
    Ziemssen T; Derfuss T; de Stefano N; Giovannoni G; Palavra F; Tomic D; Vollmer T; Schippling S
    J Neurol; 2016 Jun; 263(6):1053-65. PubMed ID: 26705122
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Visual impairment and retinal and brain neurodegeneration: A population-based study.
    Garzone D; Finger RP; Mauschitz MM; Koch A; Reuter M; Breteler MMB; Aziz NA
    Hum Brain Mapp; 2023 May; 44(7):2701-2711. PubMed ID: 36852616
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Keep Your Eyes Wide Open: On Visual- and Vision-Related Measurements to Better Understand Multiple Sclerosis Pathophysiology.
    Backner Y; Levin N
    J Neuroophthalmol; 2018 Mar; 38(1):85-90. PubMed ID: 29438265
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Diagnostic methods used in searching for markers of atrophy in patients with multiple sclerosis.
    Puz P; Steposz A; Lasek-Bal A; Bartoszek K; Radecka P; Karuga-Pierścieńska A
    Neurol Res; 2018 Feb; 40(2):110-116. PubMed ID: 29168666
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The natural history of brain volume loss among patients with multiple sclerosis: a systematic literature review and meta-analysis.
    Vollmer T; Signorovitch J; Huynh L; Galebach P; Kelley C; DiBernardo A; Sasane R
    J Neurol Sci; 2015 Oct; 357(1-2):8-18. PubMed ID: 26238166
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Substantial adverse association of visual and vascular comorbidities on visual disability in multiple sclerosis.
    Marrie RA; Cutter G; Tyry T
    Mult Scler; 2011 Dec; 17(12):1464-71. PubMed ID: 21844067
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Identification of posterior visual pathway lesions and MRI burden in people with Multiple Sclerosis.
    Daqqaq TS
    Neurosciences (Riyadh); 2021 Apr; 26(2):120-127. PubMed ID: 33814364
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Upside-down reversal of vision in multiple sclerosis.
    Doğulu CF; Kansu T
    J Neurol; 1997 Jul; 244(7):461. PubMed ID: 9266467
    [No Abstract]   [Full Text] [Related]  

  • 80. Cognitive Impairment in Multiple Sclerosis.
    Trenova AG; Slavov GS; Manova MG; Aksentieva JB; Miteva LD; Stanilova SA
    Folia Med (Plovdiv); 2016 Sep; 58(3):157-163. PubMed ID: 27760012
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.